Vildagliptin-d3 607ZD 9272 Treatment with ABR-238901 during the

Treatment with ABR-238901 during the first 3 days post-myocardial infarction (MI) restricts the inflammatory damage and promotes a reparatory environment

InChi: InChI=1S/C13H11F2NO/c14-11-7-6-9(8-16)12(15)13(11)17-10-4-2-1-3-5-10/h1-7H

InChi: InChI=1S/C11H14O3/c12-9-4-6-10(7-5-9)14-11-3-1-2-8-13-11/h4-7

Isosorbide Mononitrate is a drug used principally in the treatment of angina pectoris and acts by dilating the blood vessels so as to reduce the blood pressure

InChi: InChI=1S/C22H12ClF3N2O4/c23-17-8-6-13(10-15(17)21(30)31)28-20(29)16(19(27-28)22(24

Vildagliptin-d3 607ZD 9272 Treatment with ABR-238901 during theVildagliptin d3 (LAF237 d3) is the deuterium labeled Vildagliptin. Vildagliptin (LAF237) is a potent, stable, selective dipeptidyl peptidase IV (DPP IV) inhibitor with an IC50 of 3. 5 nM in human Caco 2 cells. Vildagliptin possesses excellent oral bioavailability and potent antihyperglycemic activity. Product information CAS Number: 1217546 82 1 Molecular Weight: 306. 42 Formula: C17H25N3O2 Chemical Name: (2S) 1 (2 {[(5R,7S) 3 hydroxyadamantan 1